GLP1R and familial pancreatic carcinoma: Until now though, almost all reviews have focused on pancreatic cancer, and no review studying the association of GLP-1 receptor agonists with all types of malignant neoplasms has been published, despite the availability of data for the incidence of various types of cancer, including breast cancer, prostate cancer, and others, in patients taking GLP-1 receptor agonists.